Almstead Neil Gregory's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Jun 24, 2026
- Accession no.
- 0001578850-26-000014
- Filed
- Jun 24, 2026
- Trade date
- Jun 22, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.92M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Almstead Neil GregoryCIK 0001578850 | Officer (CHIEF TECHNICAL OPS OFFICER) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Common Stock | MOption exerciseAcquired | +23,749 | $25.69 | +$610,111.81 | 83,886 | Direct | |
| Jun 22, 2026 | Common Stock | SSaleDisposed | −12,130 | $80.61F2 | −$977,799.3 | 71,756 | Direct | |
| Jun 22, 2026 | Common Stock | SSaleDisposed | −11,619 | $81.21F3 | −$943,578.99 | 60,137 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 | Common Stock | MOption exerciseDisposed | −23,749 | $0.00 | $0 | 23,751 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $80.00 to $80.99 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $81.00 to $81.57 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.